p53 Orchestrates the Immunogenic-Tolerogenic Pyroptosis Switch in Non-Small Cell Lung Cancer: A Systems Biology

Shantanu Gupta1, Daner A Silveira2, Rodrigo Juliani Siqueira Dalmolin1

  • 1Bioinformatics Multidisciplinary Environment-BioME-Digital Metropole Institute, Federal University of Rio Grande do Norte, Natal 59076550, RN, Brazil.

Insights

Tumor suppressor p53 regulates cell death pathways in non-small cell lung cancer (NSCLC). A new model reveals p53 controls a switch between pyroptosis and apoptosis, impacting therapy resistance.

Area of Science:

  • Cellular biology
  • Cancer research
  • Systems biology

Background:

  • Therapy failure in non-small cell lung cancer (NSCLC) is linked to resistance to immunogenic cell death.
  • The tumor suppressor p53 can initiate two distinct pyroptosis pathways: canonical (NLRP3-caspase-1-GSDMD) and secondary (caspase-9/3-GSDME).
  • The coordination logic of these parallel p53-regulated cell death pathways is not well understood, hindering therapeutic strategies.

Purpose of the Study:

  • To elucidate the systems-level logic governing p53-regulated pyroptosis pathways in NSCLC.
  • To model the decision-making process that directs cell death outcomes.
  • To identify therapeutic targets for overcoming resistance to immunogenic cell death.

Main Methods:

  • Development of the first dynamic Boolean network model for p53-regulated pyroptosis in NSCLC.
  • Analysis of feedback loops governing the terminal caspase-gasdermin axis.
  • Validation of model predictions using NSCLC cell line phenotypes and patient transcriptomics.

Main Results:

  • The p53-regulated terminal caspase-gasdermin axis functions as a bistable immunogenic switch.
  • Interlocked feedback loops, including a double-negative motif and a reinforcing loop, control pathway mutual exclusivity and commitment to secondary pyroptosis.
  • Loss of GSDME, common in NSCLC, is predicted to redirect p53-activated caspase-3 towards apoptosis, explaining evasion of immunogenic lysis.
  • Coordinated repression of pyroptosis-execution genes and identification of CASP9/GSDME as adverse prognostic markers.

Conclusions:

  • p53 acts as a central coordinator of a terminal cell fate-switch network, not just a linear activator.
  • The study provides a systems-level framework for understanding how cell death execution circuits influence outcomes in NSCLC.
  • This framework can guide the development of novel therapeutic strategies targeting cell death pathways in NSCLC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...